caryophyllene and Escherichia-coli-Infections

caryophyllene has been researched along with Escherichia-coli-Infections* in 1 studies

Other Studies

1 other study(ies) available for caryophyllene and Escherichia-coli-Infections

Article	Year
Antibacterial and Analgesic Properties of Beta-Caryophyllene in a Murine Urinary Tract Infection Model. Molecules (Basel, Switzerland), 2023, May-17, Volume: 28, Issue:10 Beta-caryophyllene has demonstrated anti-inflammatory effects in a variety of conditions, including interstitial cystitis. These effects are mediated primarily via the activation of the cannabinoid type 2 receptor. Additional antibacterial properties have recently been suggested, leading to our investigation of the effects of beta-caryophyllene in a murine model of urinary tract infection (UTI). Female BALB/c mice were intravesically inoculated with uropathogenic Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Escherichia coli Infections; Female; Mice; Urinary Tract Infections	2023

Article

Year

Antibacterial and Analgesic Properties of Beta-Caryophyllene in a Murine Urinary Tract Infection Model.

Molecules (Basel, Switzerland), 2023, May-17, Volume: 28, Issue:10

Beta-caryophyllene has demonstrated anti-inflammatory effects in a variety of conditions, including interstitial cystitis. These effects are mediated primarily via the activation of the cannabinoid type 2 receptor. Additional antibacterial properties have recently been suggested, leading to our investigation of the effects of beta-caryophyllene in a murine model of urinary tract infection (UTI). Female BALB/c mice were intravesically inoculated with uropathogenic

Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Escherichia coli Infections; Female; Mice; Urinary Tract Infections

2023